Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remifemin for LHRH-a Induced Climacteric Symptoms in Breast Cancer
NCT03339882Phase 2Completed
- Sponsor
- Zhejiang Cancer Hospital
- Start
- Jan 2017
- Primary completion
- Nov 2017
- Modality
- Botanical Extract, Dietary Supplement
- Countries
- 1
01
Overview
A Phase 2 trial of cimicifuga racemosa in menopause, sponsored by Zhejiang Cancer Hospital. Started Jan 2017; status: completed.
02
Drugs
cimicifuga racemosa
03
Conditions
menopause
Beyond the preview
Go deeper on NCT03339882.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03339882.